drugset / Trial / NCT05356091
Quality of Recovery of Remimazolam Versus Sevoflurane in Transurethral Bladder Resection.
RandomizedParallel-groupTriple-blindOther
Summary
This study was designated to investigate the quality of recovery after transurethral bladder resection. Because, patients undergoing transurethral bladder resection are mostly old age, and because of catheter-related bladder discomfort are common after transurethral bladder resection, study on the quality of recovery after transurethral bladder resection seems to be meaningful. In general, sevoflurane is commonly used as an anesthetic agent for general anesthesia of transurethral bladder resection. The purpose of this study is to investigate whether remimazolam is not inferior to sevoflurnane in terms of quality of recovery after transurethral bladder resection.
Timeline
- Start
- 2022-12-02
- Primary completion
- 2023-02-24
- Completion
- 2023-02-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Remimazolam | Small molecule | — | — |
| Comparator | Sevoflurane | Other / unclassified | — | — |
Indications
No indication recorded.